Recommended Pages at firstwordplus.com

RT @soulflsepulcher: RT @fwpharma Shire files US lawsuit against Watson over generic Adderall XR http://bit.ly/fYopWp #ADHD

Johnson & Johnson, Merck & Co.'s Simponi recommended by NICE for psoriatic arthritis - FirstWord

firstwordplus.com — “Johnson & Johnson, Merck & Co.'s Simponi recommended by NICE for psoriatic arthritis - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on March 17, 2011 at 1:34 pm By:

PsoriasisTx.com Dermatology and Health Site

RT @fwpharma: Johnson & Johnson, Merck & Co.'s Simponi recommended by NICE for psoriatic arthritis http://bit.ly/hg74Hc

FDA expands approval of Shire's ADHD drug Intuniv - FirstWord

firstwordplus.com — “FDA expands approval of Shire's ADHD drug Intuniv - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on February 28, 2011 at 4:37 pm By:

RT @soulflsepulcher: RT @fwpharma FDA expands approval of Shire's ADHD drug Intuniv http://bit.ly/fc1CBj

NICE rejects Roche's Avastin for breast cancer - FirstWord

firstwordplus.com — “NICE rejects Roche's Avastin for breast cancer - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on February 23, 2011 at 9:21 am By:

RT @fwpharma: NICE rejects Roche's Avastin for breast cancer http://bit.ly/fbTCor

Novo Nordisk served US subpoena over NovoLog, Levemir, Victoza marketing - FirstWord

firstwordplus.com — “Novo Nordisk served US subpoena over NovoLog, Levemir, Victoza marketing - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on February 16, 2011 at 10:32 am By:

RT @fwpharma: Novo Nordisk served US subpoena over NovoLog, Levemir, Victoza marketing http://bit.ly/dLkSRP

WHO begins investigation into GlaxoSmithKline's Pandemrix after reports of narcolepsy - FirstWord

firstwordplus.com — “WHO begins investigation into GlaxoSmithKline's Pandemrix after reports of narcolepsy - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on February 1, 2011 at 4:34 pm By:

RT @fwpharma: WHO begins investigation into GlaxoSmithKline's Pandemrix after reports of narcolepsy http://bit.ly/g8lZ6U

Pfizer to close R&D site in UK, may cut 2400 jobs - FirstWord

firstwordplus.com — “Pfizer to close R&D site in UK, may cut 2400 jobs - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on February 1, 2011 at 2:13 pm By:

RT @fwpharma: Pfizer to close R&D site in UK, may cut 2400 jobs http://bit.ly/eAd87B

Teva, APP Pharmaceuticals to launch generic version of Eli Lilly's Gemzar - FirstWord

firstwordplus.com — “Teva, APP Pharmaceuticals to launch generic version of Eli Lilly's Gemzar - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on January 26, 2011 at 5:13 pm By:

eyeonfda Pharma and Health Lawyer

RT @fwpharma: Teva, APP Pharmaceuticals to launch generic version of Eli Lilly's Gemzar http://bit.ly/eRxkOm

Andrew von Eschenbach, M.D., former FDA commissioner and leading prostate cancer expert, elected to Viamet Pharmaceuticals board of directors - FirstWord

firstwordplus.com — “Andrew von Eschenbach, M.D., former FDA commissioner and leading prostate cancer expert, elected to Viamet Pharmaceuticals board of directors - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on January 19, 2011 at 3:17 pm By:

eyeonfda Pharma and Health Lawyer

RT @fwpharma: Andrew von Eschenbach, MD, former FDA commissioner, elected to Viamet Pharma's board of directors http://bit.ly/gHXrVX

Abbott withdraws US, EU applications for psoriasis drug briakinumab - FirstWord

firstwordplus.com — “Abbott withdraws US, EU applications for psoriasis drug briakinumab - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on January 17, 2011 at 2:24 pm By:

Skin & Aging Dermatology and Medical Journal

Abbott withdraws application for psoriasis drug briakinumab. http://bit.ly/dVkaN8

Merck & Co. shares drop 7 percent on vorapaxar study news - FirstWord

firstwordplus.com — “Merck & Co. shares drop 7 percent on vorapaxar study news - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on January 13, 2011 at 3:24 pm By:

RT @fwpharma: Merck & Co. stops treating some patients in late-stage trials of vorapaxar; shares drop 7 percent http://bit.ly/eyQggF

FierceBiotech Health News

Merck & Co. in deal with Parexel to develop biosimilars - FirstWord

firstwordplus.com — “Merck & Co. in deal with Parexel to develop biosimilars - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on January 12, 2011 at 1:28 pm By:

RT @fwpharma: Merck & Co. in deal with Parexel to develop biosimilars http://bit.ly/gWBK9I

Rob Halkes Health Marketing

Pharma YouTube Channels: Content and Comment - a Nexus report

firstwordplus.com — “Pharma YouTube Channels: Content and Comment - a Nexus report” View full resource at firstwordplus.com

Most Recently Shared on December 20, 2010 at 1:07 pm By:

1st @NexusNR commercial report just published http://bit.ly/eR8ggP Pharma Ytube channels and rankings #hcsmeu #fdasm #socpharm

FierceBiotech Health News

Sanofi-aventis, Avila Therapeutics enter cancer drug discovery deal - FirstWord

firstwordplus.com — “Sanofi-aventis, Avila Therapeutics enter cancer drug discovery deal - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on December 20, 2010 at 12:11 pm By:

RT @fwpharma: Sanofi-aventis, Avila Therapeutics enter cancer drug discovery deal http://bit.ly/fRjZvt

Rob Halkes Health Marketing

Sanofi-aventis to cut 575 jobs in France - FirstWord

firstwordplus.com — “Sanofi-aventis to cut 575 jobs in France - FirstWord” View full resource at firstwordplus.com

Most Recently Shared on December 6, 2010 at 6:00 pm By:

Sanofi-aventis to cut 575 jobs in French commercial operations - FirstWord http://t.co/t7slLwW #hcsmeu #hcsmeufr #socpharm